Lassen, Michael Rud <br/><br/>
Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial.  [electronic resource] 

 -  Lancet (London, England)  Mar 2010 
 - 807-15 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1474-547X 
<br/><br/><label>Standard No.: </label>10.1016/S0140-6736(09)62125-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Aged<br/>Anticoagulants--adverse effects<br/>Arthroplasty, Replacement, Knee<br/>Double-Blind Method<br/>Enoxaparin--adverse effects<br/>Female<br/>Fibrinolytic Agents--adverse effects<br/>Humans<br/>Injections, Subcutaneous<br/>Male<br/>Middle Aged<br/>Postoperative Complications--prevention & control<br/>Pyrazoles--adverse effects<br/>Pyridones--adverse effects<br/>Venous Thromboembolism--prevention & control